NCT07206056 2026-04-16
TulmiSTAR-01
Novartis
Phase 1/2 Recruiting
Clinical Trials
12 trialsNCT04565665 2026-04-14
Study of Cord Blood Derived Mesenchymal Stem Cells for Treatment of Moderate, Severe or Critical Pneumonia
M.D. Anderson Cancer Center
Phase 1/2 Recruiting
NCT06097468 2026-04-13
Nisin in Oral Cavity Squamous Cell Carcinoma (OCSCC)
University of California, San Francisco
Phase 1/2 Recruiting
NCT06502691 2026-03-02
[18F]FTT Positron Emission Tomography for the Measurement of PARP Tumor Expression in Patients With Metastatic Breast Cancer
University of Washington
Phase 1/2 Recruiting
NCT05405595 2026-01-07
ADG126 in Combination With Pembrolizumab in Patients With Advanced/Metastatic Solid Tumors
Adagene Inc
Phase 1/2 Recruiting
NCT07053462 2025-07-08
CRISPR-Edited HLA Donor Kidney Transplant to Reduce Rejection Risk
AMERICAN ORGAN TRANSPLANT AND CANCER RESEARCH INSTITUTE LLC
Phase 1/2 Recruiting
NCT04497142 2024-08-05
Effect of Perampanel on Peritumoral Hyperexcitability in HGG
Dana-Farber Cancer Institute
Phase 1/2 Completed
NCT04532372 2024-07-03
Leflunomide for the Treatment of Severe COVID-19 in Patients With a Concurrent Malignancy
City of Hope Medical Center
Phase 1/2 Completed
NCT06109961 2023-11-07
HYPNOTIC
Ottawa Hospital Research Institute
Phase 1/2 Unknown
NCT04731051 2023-04-07
The Potential Use of Inhaled Hydroxychloroquine for the Treatment of COVID-19 in Cancer Patients
King Hussein Cancer Center
Phase 1/2 Withdrawn
NCT05664906 2022-12-27
Evaluating Chinese Medicine Oral Rinse for Irradiated Oral Mucositis in Head & Neck Cancer Patients
Chinese University of Hong Kong
Phase 1/2 Unknown
NCT03061110 2018-04-30
Stromal Vascular Fraction for Treatment of Xerostomia
Midwestern Regional Medical Center
Phase 1/2 Withdrawn